| Followers | 0 |
| Posts | 1357 |
| Boards Moderated | 0 |
| Alias Born | 03/20/2022 |
Thursday, March 31, 2022 12:18:25 PM
Not a clinical trials expert but this "walkdown" appears comically artifical.
Seems some fund that's been footing the bill doesnt want any of you ""unworthy"" peons along for the ride when news finally breaks...maybe???
Several of the issues mentioned in post #19945 looks to be lining up rather well with current events.
Jus sayin of course.....eyes fixed on the prize.
Oh well, back to silently observing all the obvious shenanigans by certain wankers on this board and in the Market.
Cheers!!!
Seems some fund that's been footing the bill doesnt want any of you ""unworthy"" peons along for the ride when news finally breaks...maybe???
Several of the issues mentioned in post #19945 looks to be lining up rather well with current events.
Jus sayin of course.....eyes fixed on the prize.
Oh well, back to silently observing all the obvious shenanigans by certain wankers on this board and in the Market.
Cheers!!!
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
